Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-cardioembolic Ischemic Stroke”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Large-scale testing (Phase 3)Study completedNCT04738097
What this trial is testing

Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke

Who this might be right for
Ischemic StrokeTransient Ischemic Attack
Mazandaran University of Medical Sciences 90
Large-scale testing (Phase 3)Study completedNCT02898610
What this trial is testing

Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke

Who this might be right for
Ischemic Attack, TransientStroke
University College Dublin 3,154
Post-approval studies (Phase 4)Study completedNCT00004727
What this trial is testing

Antiplatelet Therapy to Prevent Stroke in African Americans

Who this might be right for
StrokeCerebral Infarction
National Institute of Neurological Disorders and Stroke (NINDS)
Post-approval studies (Phase 4)Study completedNCT05445895
What this trial is testing

Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke

Who this might be right for
Ischemic Stroke
SK Chemicals Co., Ltd. 483
Large-scale testing (Phase 3)Study completedNCT05686070
What this trial is testing

Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

Who this might be right for
Prevention of Ischemic StrokeAcute Non-cardioembolic Ischemic StrokeHigh-risk Transient Ischemic Attack
Bayer 12,327
Post-approval studies (Phase 4)UnknownNCT04504864
What this trial is testing

Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds

Who this might be right for
Ischemic Stroke
Xijing Hospital 400
Large-scale testing (Phase 3)Looking for participantsNCT06653348
What this trial is testing

Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke

Who this might be right for
Ischemic StrokeTransient Ischemic Attack
Mazandaran University of Medical Sciences 100
Not applicableStudy completedNCT01410396
What this trial is testing

Occult Paroxysmal Atrial Fibrillation in Patients With Non-cardioembolic Ischemic Stroke of Determined Mechanism

Who this might be right for
Atrial FibrillationStroke
Northwestern University 49
Not applicableEnrolling By InvitationNCT06551727
What this trial is testing

Antithrombotic Therapy With Regulation of Blood Pressure in Non-Cardioembolic Progressive Stroke

Who this might be right for
Stroke, Ischemic
Ruijin Hospital 70
Testing effectiveness (Phase 2)Study completedNCT04304508
What this trial is testing

Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain.

Who this might be right for
Acute Non-cardioembolic Ischemic Stroke
Bayer 1,808
Not applicableUnknownNCT04684732
What this trial is testing

Relationship Between Renal Function and Pharmacokinetics of Apixaban and Clinical Outcome of Apixaban in Thai Non-valvular Atrial Fibrillation Patients

Who this might be right for
Atrial Fibrillation
Chulalongkorn University 241
Large-scale testing (Phase 3)UnknownNCT01600235
What this trial is testing

Safety and Efficacy of Therapeutic INduced HYPERTENSION in Acute Non-cardioembolic Ischemic Stroke (SETIN-HYPERTENSION)

Who this might be right for
Stroke, AcuteProgressing Stroke
Samsung Medical Center 170
Early research (Phase 1)Study completedNCT05419635
What this trial is testing

Learn How the Study Treatment Asundexian Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body in Participants With Mild or Moderate Reduction of Liver Function Compared to Participants With Normal Liver Function

Who this might be right for
Prevention of Thromboembolic EventsAtrial FibrillationAcute Myocardial Infarction+2 more
Bayer 27